Spect - About the company
Spect is a seed company based in San Francisco (United States), founded in 2017 by Rishab Gargeya. It operates as an AI-powered platform for accessible eye disease screening and vision health. Spect has raised $5.18M in funding from investors like Y Combinator, AME Cloud Ventures and Morado Ventures, with a current valuation of $*****. The company has 50 active competitors, including 4 funded and 2 that have exited. Its top competitors include companies like Smartlens, 6over6 and Visibly.
Company Details
AI-powered platform for accessible eye disease screening and vision health. This innovative enterprise solution aims to prevent blindness through early detection of eye diseases. It addresses critical healthcare gaps by providing best-in-class service with a portable retinal camera that enables retinal exams anywhere. The platform integrates seamlessly into existing clinical workflows, allowing medical staff to conduct exams in minutes. A human-in-the-loop assisted telemedicine platform ensures quick, gradable exams with reports delivered promptly. The solution screens for various eye diseases, leveraging AI for image capture and grading in the future. It is FDA registered, SOC certified, and HIPAA compliant, ensuring data privacy and security. The platform supports Accountable Care Organizations, Community Health Centers, Payors, Health Systems, and more, improving eye care access and outcomes.
Key Metrics
Founded Year
2017
Location
San Francisco, United States
Stage
Seed
Total Funding
$5.18M in 4 rounds
Latest Funding Round
Post Money Valuation
$***** as on Aug 24, 2017
Investors
Ranked
4th among 50 active competitors
Employee Count
10 as on Jul 01, 2024
Legal entities associated with Spect
Spect is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Spect Inc. CIN: 821671528 , United States, Active | Dec 31, 2016 | - | - | - |
Sign up to download Spect's company profile
Spect's funding and investors
Spect has raised a total funding of $5.18M over 4 rounds. Its first funding round was on Aug 24, 2017. Its latest funding round was a Seed round on Nov 30, 2021 for $*****. 4 investors participated in its latest round. Spect has 9 institutional investors.
Here is the list of recent funding rounds of Spect:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 30, 2021 | 5778943 | Seed | 2745088 | 2778577 | 9598479 | 2988667 |
Sep 26, 2018 | 6376950 | Grant (prize money) | 2829189 | 8131000 | 3127239 | |
Sep 12, 2017 | 2249158 | Seed | 6261346 | 1681458 | 7114061 | 9609409 |
View details of Spect's funding rounds and investors
Spect's founders and board of directors
Founder? Claim ProfileThe founders of Spect is Rishab Gargeya. Rishab Gargeya is the CEO of Spect.
Here are the details of Spect's key team members:
- Rishab Gargeya: Co-Founder & CEO of Spect. Contact Info: 1 email address and 1 phone number
View details of Spect's Founder profiles and Board Members
Spect's employee count trend
Spect has 10 employees as of Jul 24. Here is Spect's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Spect's Competitors and alternates
Top competitors of Spect include Smartlens, 6over6 and Visibly. Here is the list of Top 10 competitors of Spect, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Smartlens 2015, Mountain View (United States), Series A | Provider of a non-invasive device for measuring eye pressure (IOP) | $11.3M | 59/100 | |
2nd | Mobile apps for optometry | $11M | 52/100 | ||
3rd | Visibly 2012, Chicago (United States), Series B | Online vision test technology for providers | $56.2M | 51/100 | |
4th | Spect 2017, San Francisco (United States), Seed | AI-powered platform for accessible eye disease screening and vision health | $5.18M | 44/100 | |
5th | Color Blind Check 2014, Regensdorf (Switzerland), Unfunded | Provider of mobile app to check color blindness | - | - | 40/100 |
6th | Provider of eye protection and monitoring software for patients | - | - | 40/100 | |
7th | Provider of an app for preventing myopia | - | 39/100 | ||
8th | Easee 2016, Amsterdam (Netherlands), Acquired | App for eye test | - | 38/100 | |
9th | Eyecare- Amsler Grid Eye Test 2015, United States, Unfunded | Provider of mobile app for vision loss people | - | - | 36/100 |
10th | Visual Acuity 2018, Wakerley (Australia), Unfunded | Provider of software solutions for visual care | - | - | 36/100 |
Looking for more details on Spect's competitors? Click here to see the top ones
Spect's Investments and acquisitions
Spect has made no investments or acquisitions yet.
Reports related to Spect
Here is the latest report on Spect's sector:
News related to Spect
•
•
Writer, the Full-Stack Generative AI Platform, Announces $100 Million Series B to Help Deliver Generative AI to the EnterpriseInsight Partners•Sep 18, 2023•Insight Partners, WRITER, Iconiq Capital, Balderton Capital and 9 others
•
•
MedTech Innovator Names Sana Health as 2018 Global Competition Winner at The MedTech ConferenceMedTech Innovator•Sep 26, 2018•Spect
Are you a Founder ?
FAQs about Spect
Explore our recently published companies
- Wrigby - United Kingdom based, Unfunded company
- Grizone Trans-India Logistcs - 2012 founded, Unfunded company
- Massive Design - Canada based, Unfunded company
- Mathemagical - San Francisco based, 2019 founded, Unfunded company
- Mdweb - Canada based, Unfunded company
- Freewheeling: entrepreneurial approaches to transport & mobility - London based, 2024 founded, Unfunded company